Fig. 1 · Structure
Documents & Downloads
KW-2149
Mitomycin C Analogue
KW-2149 is a Mitomycin C analogue that functions by binding to DNA upon activation by serum. This compound demonstrates significant antitumor activity, making it a valuable tool for cancer research, particularly in the study of leukemia. It is important to note that KW-2149 may exhibit pulmonary toxicity.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 118359-59-4 |
| Applications | Mitomycin C Analogue |
| Formula | C24H34N6O8S2 |
| Molecular Weight | 598.69 |
| Synonyms | KT-6149 |
| SMILES | CO[C@]12N(C[C@@]3([H])[C@]2([H])N3)C4=C(C(C(NCCSSCCNC(CC[C@H](N)C(O)=O)=O)=C(C4=O)C)=O)[C@H]1COC(N)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.